Publications

Hu, S., Santhireswaran, A., Chu, C., Chaudhry, S., Yang, C., Fang, Y., Suda, K.J., Gaudette, E., Grundy, Q., Tadrous, M. (2025). The association between drug shortages and prices across 74 countries: Uncovering global access inequities. BMJ Global Health, 10, e018960. doi:10.1136/bmjgh-2025-018960.

Grundy, Q. (2025). Delivering the script: The educational activities of medical device industry representatives as a knowledge management strategy. Social Science & Medicine, 384, 118565. doi: 10.1016/j.socscimed.2025.118565.

Eisenkraft-Klein, D., Grundy, Q., Hawkins, B. & Schwartz, R. (2025). Reframing the overdose crisis: Stigma, industry influence and the politics of abuse-deterrent opioids. Int J of Social Determinants of Health and Health Services. doi: 10.1177/27551938251378941.

Eisenkraft-Klein, D., Grundy, Q., Hawkins, B. & Schwartz, R. (2025). Framing coalitions and the Canadian overdose crisis: The case of opioid marketing. Social Science & Medicine, 381, 118247. doi: 10.1016/j.socscimed.2025.118247.

Eisenkraft-Klein, D., Grundy, Q., Hawkins, B. & Schwartz, R. (2025). Constructing opioid legitimacy: The Canadian Pain Task Force's framings of the overdose crisis. Journal of Law, Medicine, and Ethics, 1-9. doi:10.1017/jme.2025.10158

Graham, S.S., Grundy, Q., Sharma, N., Edward, J.S., Barbour, J.B., Rousseau, J.F., Majdik, Z.P., & Bero, L. (2025). Research on policy mechanisms addressing industry funding, industry affiliation, and conflicts of interest in biomedical research: A scoping review. Research Integrity and Peer Review, 10(6). doi: 0.1186/s41073-025-00164-0.

Spithoff, S., McPhail, B., Vesley, L., Rowe, R.K., Mogic, L., & Grundy, Q. (2025). The primary care medical record industry in Canada and its data collection and commercialization practices. JAMA Network Open, 8(5), e257688. doi:10.1001/jamanetworkopen.2025.7688.

Henke-Ciążyńska, K., Pankowski, D., Munblit, D., Fabbri, A., Grundy, Q., Bero, L., & Helfer, B. (2025). Financial ties of paediatric allergy and immunology professional associations with the formula milk industry: a global cross-sectional study. Clinical and Experimental Allergy. doi: 10.1111/cea.70064

Adam, F., Nelson, S., Salami, B., Grundy, Q., & Abdul-Wahab, O. (2025). Decisions and pathways of African nurses’ international migration: A scoping review. BMC Health Services Research, 25, 419. doi: 10.1186/s12913-025-12531-0.

Grundy, Q., Hart, D., Elkhalifa, S., Lexchin, J., Gagnon, M.A., Persaud, N., & Tadrous, M. (2025). Mapping the landscape of infusion care for people prescribed intravenous medicines in Canada. Canadian Journal of Health Technologies, 5(1). doi: 10.51731/cjht.2025.1066  

Buchman, D.Z., Magel, B., Shier, R., Davies, E.T., Sud, A., Mahajan, S., Timothy, R.K., Soklaridis, S. & Grundy, Q. (2025). Canadian cannabis researcher perspectives on the conduct and sponsorship of scientific research by the for-profit cannabis industry. Social Science & Medicine, 364, 117556. doi: 10.1016/j.socscimed.2024.117556

MacIsaac, M., Rudner, N., Klein, T., Ladd, E., Hart, D., Baugh, C.M., & Grundy, Q. (2024). Open Payments: Public reporting of industry payments to APRNs. The Journal for Nurse Practitioners, 20(10), 105134. doi: 10.1016/j.nurpra.2024.105134.

Grundy, Q., Rudner, N., Klein, T., Ladd, E., Hart, D., MacIsaac, M., & Bero, L. (2024). "I never thought of it as payment": Qualitative evaluation of workshops with advanced practice registered nurses on pharmaceutical industry payment reporting. Journal of the American Association of Nurse Practitioners, 37(1), 51-60. doi: 10.1097/JXX.0000000000001077.

Mor, J., Kaur, T., Menkes, D., Peter, E. & Grundy, Q. (2024). Pharmaceutical industry promotional activities on social media: A scoping review. Journal of Pharmaceutical Health Services Research, 15(4). doi: 10.1093/jphsr/rmae022.

Mohammed, S. Bytautas, J., & Grundy, Q. (2024). Addressing post-truth in the classroom: Towards a critical pedagogy. Teaching and Learning Inquiry, 12, 1-16. doi: 10.20343/teachlearninqu.12.24

Holloway, K., Chauhan, D., Majid, U., Kelly, S. & Grundy, Q. (2024). Chaos, miracle, and coping: A narrative analysis of immunoglobulin recipients’ lived experiences of illness, diagnosis and treatment. SSM – Qualitative Health Research, 6, 100467. doi: 10.1016/j.ssmqr.2024.100467

Holloway, K. & Grundy, Q. (2024). Toward a sociology of plasma products. International Journal of Social Determinants of Health and Health Services. doi: 10.1177/27551938241269136

Grundy, Q., Held, F., MacIsaac, M., Baugh, C.M., Campbell, E.G., & Bero, L. (2024). Quantifying industry spending on promotional events using Open Payments data. JAMA Health Forum, 5(6), e241581. doi:10.1001/jamahealthforum.2024.1581.

Grundy, Q., Campbell, C., Ali, R., Herder, M. & Holloway, K. (2024). ‘A most equitable drug’: How the failed treatment of convalescent plasma against SARS-CoV-2 might usefully inform post-pandemic public sector clinical trials for drug development. J Law Med Ethics, 52(1), 80-97. doi:10.1017/jme.2024.51.

Spithoff, S., McPhail, B., Vesley, L., Rowe, R.K., Mogic, L. & Grundy, Q. (2024) How the virtual care industry gathers, uses and values patient data: a Canadian qualitative study. BMJ Open, 14, e074019. doi: 10.1136/bmjopen-2023-074019.

Gorodensky, A., Grundy, Q., Persaud, N. & Kohler, J. (2023). Shared health governance, mutual collective accountability, and transparency in COVAX: A qualitative study triangulating data from document sampling and key informant interviews. Journal of Global Health, 13, 04165, doi: 10.7189/jogh.13.04165.

Grundy, Q., Held, F., Hart, D., Baugh, C.M., Ladd, E., Campbell, E., & Bero, L. (2023). Characteristics of advanced practice nurses receiving top industry payments and their practice settings: A cross-sectional study. J General Internal Medicine. doi: 10.1007/s11606-023-08508-6

Grundy, Q., Quanbury, A., Hart, D., Chaudhry, S., Tavangar, F., Lexchin, J., Gagnon, MA., & Tadrous, M. (2023). The prevalence and characteristics of pharmaceutical industry patient support programs for prescription medicines: A cross-sectional study. CMAJ, 195(46): E1565-E1576. doi: 10.1503/cmaj.230841

Pimienta, J., Bethe, T., Brandt, J., Holz, R., Continella, A., Jibb, L., & Grundy, Q. (2023). Mobile apps and children’s privacy: A traffic analysis of data sharing practices among children’s mobile iOS apps. Archives of Disease in Childhood.

Owadally, T., & Grundy, Q. From a criminal to a human-rights issue: Re-imagining policy solutions to homelessness. Policy, Politics, & Nursing Practice. 2023;0(0). doi:10.1177/15271544231176255

Grundy, Q., Hart, D., Perkins-Meingast, B., Heesters, A. & Miller, F. (2023). Outsourcing practice-based education: The role of industry representatives and implications for clinical expertise. Healthcare Management Forum. doi: 10.1177/08404704231173552.

Spithoff, S., & Grundy, Q. (2023). Commercializing personal health information: A critical qualitative content analysis of documents describing proprietary care databases in Canada. International Journal of Health Policy and Management, 12(1), 1-11. doi: 10.34172/ijhpm.2023.6938.

Gamage, K., Chiu, K., Ryk, J., Grundy, Q., Sud, A. (2023). How policy problems and solutions travel in the scientific literature: An international scientometric analysis of the French Model of opioid use disorder care. J Evaluation in Clinical Practice, 29(4), 576-590. doi: 10.1111/jep.13822. 

Grundy, Q., Imahori, D., Mahajan, S., Timothy, R., Garner, G., Sud, A., Soklaridis, S. & Buchman, D.Z. (2023). Cannabis companies and the sponsorship of scientific research: A cross-sectional Canadian case study. PLoS ONE, 18(1): e0280110. doi:10.1371/journal.pone.0280110.

Grundy, Q., Davenport Huyer, L., Parker, L. & Bero, L. (2022). Branded care: The policy implications of pharmaceutical industry-funded nursing care related to specialty medicines. Policy, Politics, and Nursing Practice. doi: 10.1177/15271544221121749

Sud, A., Strang, M., Buchman, D., Spithoff, S., Webster, F., Upshur, R. & Grundy, Q. (2022). Dispensing education: Pharmaceutical industry promotion of Suboxone® during the opioid crisis. BMJ Open, 12(7): e059561

Holloway, K., Campbell, C., Ali, R., Davenport Huyer, L., Hart, D., Haw, J., Brennenstuhl, S. & Grundy, Q. (2022). A critical contribution in a time of crisis: Examining motivations and deterrents to COVID-19 convalescent plasma donation and future donation intentions among prospective Canadian donors. Transfusion Medicine, 32(5), 351-365. doi:10.1111/tme.12875.

Blakely, B., Rogers, W., Johnson, J., Grundy, Q., Hutchison, K., Clay-Williams, R., Richards, B. and Maddern, G. (2022). Ethical and regulatory implications of the COVID-19 pandemic for the medical devices industry and its representatives. BMC Med Ethics 23, 31. doi: 10.1186/s12910-022-00771-2.

Grundy, Q., Parker, L., Wong, A., Fusire, T., Dimancesco, D., Tisocki, K., Walkowiak, H., Vian, T. & Kohler, J. (2022). Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region. Globalization & Health 18, 33 (2022). doi: 10.1186/s12992-022-00822-8

Jibb, L., Amoako, E., Heisey, M., Ren, L., & Grundy, Q. (2022). Data handling practices and commercial features of apps related to children: a scoping review of content analyses. Archives of Disease in Childhood. doi: 10.1136/archdischild-2021-323292

Grundy, Q, & Parker, L. (2022). Conflict of interest management policies and practices in the public pharmaceutical sector in South-East Asia Region. New Delhi, India: World Health Organization South-East Asia Region Office (SEARO).

Grundy, Q., Millington, A., Robinson, A., Held, F. & Fabbri, A. (2022). Exposure, access and interaction: A global analysis of sponsorship of nursing professional associations. J Advanced Nursing, 78(4), 1140-1153. doi: 10.1111/jan.15158

Persaud, N., Ally, M., Woods, W., Workentin, A., Baxter, N.N., Boozary, A., Grundy, Q., Lofters, A., McKenzie, K., Pinto, A., Schünemann, H.J., & Straus, S. (2022). Inclusion of racialised people in clinical practice guideline panels: cross-sectional study. The Lancet. doi: 10.1016/S0140-6736(21)02759-8

Grundy, Q. (2022). A review of the impact and quality of mobile health apps. Annual Review of Public Health, 43. doi: 10.1146/annurev-publhealth-052020-103738.

Bero, L., Lawrence, R. Leslie, L., Chiu, K.,* McDonald, S.,* Page, M.J., Grundy, Q., Parker, L., Boughton, S.L., Kirkham, J.J. & Featherstone, R. (2021). Comparison of preprints and final journal publications from COVID-19 studies: Discrepancies in results reporting and spin in interpretation. BMJ Open, 11: e051821. doi:10.1136/ bmjopen-2021-051821.

Grundy, Q., Jibb, L., Amoako, E. & Fang, G. (2021). Health apps are designed to track and share. BMJ, 373, n1429. doi: 10.1136/bmj.n1429.

Grundy, Q. (2021). A politics of objectivity: Evidence-based medicine’s attempts to grapple with “non-financial” conflicts of interest. Science and Engineering Ethics, 27(3):37. doi: 10.1007/s11948-021-00315-8.

Fabbri A., Hansen, C., Grundy, Q., Bero, L., Dunn, A. Mohammed, A. & Mintzes, B. (2021). Association between conflicts of interest and authors’ positions on harms of varenicline: a cross-sectional analysis. J Gen Int Med. doi: 10.1007/s11606-021-06915-1.

Grundy, Q., Mazzarello, S., Brennenstuhl, S., & Karanges, E.A. (2021). A comparison of educational events for physicians and nurses in Australia sponsored by opioid manufacturers. PLOS ONE, 16(3): e0248238. doi:10.1371/journal.pone.0248238.

Parker, L., Grundy, Q., Fabbri, A., Mintzes, B. & Bero, L. (2021). “Lines in the sand” - An Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders. BMJ Open, 11:e045140. doi: 10.1136/bmjopen-2020-045140.

Traversy, G., Barnieh, E., Akl, E.A., Allan, G.M., Brouwers, M., Ganache, I., Grundy, Q., Guyatt, G.H., Kelsall, D., Leng, G., Moore, A., Persaud, N., Schünemann, H.J., Straus, S., Thombs, B.D., Rodin, R., & Tonelli, M. (2021). Managing conflicts of interest in the development of health guidelines. CMAJ, 193, E49-54. doi: 10.1503/cmaj.200651

Wang, Z. Grundy, Q., & Bero, L. (2021). Understanding professional stakeholders’ active resistance to guideline implementation: The case of Canadian breast screening guidelines. Social Science and Medicine, 269: 113586. doi: 10.1016/j.socscimed.2020.113586.

Grundy, Q., Krasik, O., Meleca, N., Mills, N., Nour, S. & Whalen, E. (2020). Beyond engagement: Realising nurses’ capacity to lead sustainable health systems. Healthcare Papers 19(3), 67-73. doi:10.12927/hcpap.2020.26369

Parker, L., Bennett, A., Mintzes, B., Grundy, Q., Fabbri, A., Karanges, E.A., & Bero, L. (2020). ‘There are ways . . drug companies will get into DTC decisions”: How Australian Drug and Therapeutics Committees address pharmaceutical industry influence. British Journal of Clinical Pharmacology. doi: 10.1111/bcp.14636.

Wang, Z., Grundy, Q., Parker, L. & Bero, L. (2020). Variations in systems for guideline adaptation: A qualitative study of experiences with WHO guidelines. BMC Public Health, 20:1758. doi: 10.1186/s12889-020-09812-0

Grundy, Q., Cussen, C. & Dale, C. (2020). Constructing a problem and marketing solutions: A critical content analysis of the nature and function of industry-authored oral health educational materials. Journal of Clinical Nursing, 29(23-24), 4697-4707. doi: 10.1111/jocn.15510

Grundy, Q., Mazzarello, S. & Bero, L. (2020). A comparison of policy provisions for managing “financial” and “non-financial” interests across health-related research organizations: A qualitative content analysis. Accountability in Research, 27(4): 212-237. doi: 10.1080/08989621.2020.1748015

Grundy, Q., Dunn, A., & Bero, L. (2020). Improving researchers’ conflict of interest declarations. BMJ, 368:m422. doi: 10.1136/bmj.m422.

Grundy, Q., Mayes, C., Holloway, K, Mazzarello, S., Thombs, B. & Bero, L. (2020). Conflict of interest as ethical shorthand: Understanding the range and nature of “non-financial conflicts of interest” in biomedicine. J Clinical Epidemiology, 120: 1-7. doi: 10.1016/j.jclinepi.2019.12.014

Chartres, N., Grundy, Q., Parker, L., & Bero, L. (2020). “It’s not smooth sailing”: Bridging the gap between methods and content expertise in public health guideline development. International J Health Policy & Management.

Bero, L., Chiu, K., & Grundy, Q. (2019). The SSSPIN study—spin in studies of spin: meta-research analysis. BMJ, 367:l6202. doi:10.1136/bmj.l6202.

Parker, L., Fabbri, A., Grundy, Q., Mintzes, B. & Bero, L. (2019). “Asset exchange”—interactions between patient groups and pharmaceutical industry: Australian qualitative study. BMJ, 367, l6694. doi: 10.1136/bmj.l6694.

Wang, Z., Grundy, Q., Parker, L., & Bero, L. (2019). Health promoter, advocate, legitimiser — the many roles of WHO guidelines: a qualitative study. Health Research Policy & Systems, 17, 96. doi: 0.1186/s12961-019-0489-z.

Grundy, Q., Chiu, K. & Bero, L. (2019). Commercialization of user data by developers of medicines-related apps. Journal of General Internal Medicine. doi: 10.1007/s11606-019-05214-0.

Grundy, Q. (2019). Choosing Wisely in the context of corporate influence. HealthcarePapers, 18(1), 25-29. doi: 10.12927/hcpap.2019.25872.

Karanges, E. Grundy, Q. & Bero, L. (2019). Understanding the nature and extent of pharmaceutical industry payments to nonphysician clinicians. JAMA Internal Medicine. doi: 10.1001/jamainternmed.2019.1371.

Parker, L., Halter, V., Karliychuk, T., & Grundy, Q. (2019). How private is your mental health data? An empirical study of mental health app privacy policies and practice. International Journal of Law & Psychiatry, 64: 198-204. doi: 10.1016/j.ijlp.2019.04.002.

Grundy, Q., Chiu, K., Held, F., Continella, A., Bero, L. & Holz, R. (2019). Data sharing practices of medicines-related apps: Traffic, network, and content analysis. BMJ, 364: I920. doi: 10.1136/bmj.l920

Parker, L., Bero, L., Gillies, D., Raven, M. & Grundy, Q. (2019). The “hot potato” of mental health app regulation: A critical case study of the Australian policy arena. International Journal of Health Policy and Management, 8(3):168-176. doi: 10.15171/ijhpm.2018.117

Fabbri, A., Lai, A., Grundy, Q., & Bero, L. (2018). The influence of industry sponsorship on the research agenda: A scoping review. American Journal of Public Health, 198(11):e9-e16. doi: 10.2105/AJPH.2018.304677

Parker, L., Bero, L., Gillies, D., Raven, M., Mintzes, B., Jureidini, J., & Grundy, Q. (2018). Mental health messages in prominent mental health apps. Annals of Family Medicine, 16(4), 338-342. doi: 10.1370/afm.2260

Grundy, Q., Hutchison, K., Johnson, J., Blakely, B., Clay-Williams, R., Richards, B. & Rogers, W. (2018). Device representatives in hospitals: Are commercial imperatives driving clinical decision-making? Journal of Medical Ethics, 44:589-592.  doi: 10.1136/medethics-2018-104804

Parker, L., Grundy, Q., & Bero, L. (2018). Interpreting evidence in General Practice: bias and conflicts of interest. The Australian Journal of General Practice, 47(6), 337-340. doi: 10.31128/AJGP-12-17-4432

Grundy, Q., Habibi, R., Shnier, A., Mayes, C., & Lipworth, W. (2018). Decoding disclosure: Comparing conflict of interest policy among France, Australia and the United States. Health Policy, 122(5), 509-518.

Mintzes, B., Swandari, S., Fabbri, A., Grundy, Q., Moynihan, R., & Bero, L. (2018). Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over­active bladder syndrome? An Australian cohort study. BMJ Open, 8: e019027. doi:10.1136/bmjopen-2017-019027

Grundy, Q., Dunn. A.G., Bourgeois, F.T., Coeira, E., & Bero, L. (2018). Prevalence of disclosed conflicts of interest in biomedical research and associations with journal impact factors and Altmetric scores. JAMA, 319(4):408-409. doi:10.1001/jama.2017.20738

Parker, L., Karliychuk, T., Gillies, D., Mintzes, B., Raven, M. & Grundy, Q. (2017). A health app developer's guide to law and policy: A multi-sector policy analysis. BMC Medical Informatics and Decision Making, 17: 141. doi: https://doi.org/10.1186/s12911-017-0535-0

Grundy, Q., Held, F.P., & Bero, L.A. (2017). A social network analysis of the financial links backing health and fitness apps. American Journal of Public Health. doi: 10.2105/AJPH.2017.030995

Grundy, Q., Tierney, L., Mayes, C. & Lipworth, W. (2017). Health professionals "make their choice": Pharmaceutical industry leaders' understandings of conflict of interest. Journal of Bioethical Inquiry, 14(4), 541-553. doi: 10.1007/s11673-017-9804-y

Chiu, K., Grundy, Q., & Bero, L.A. (2017). 'Spin' in published biomedical research: A methodological systematic review. PLoS Biology, 15(9): e2002173. doi: 10.1371/journal/pbio/2002173

Fabbri, A., Grundy, Q., Mintzes, B., Swandari, S., Moynihan, R., Walkom, E. & Bero, L. A. (2017). A cross-sectional analysis of pharmaceutical industry-sponsored events for health professionals in Australia. BMJ Open, 7:e016701. doi: 10.1136/bmjopen-2017-016701

Grundy, Q., Held, F. P., & Bero, L. A. (2017). Tracing the potential flow of consumer data: A network analysis of prominent health and fitness apps. Journal of Medical Internet Research (JMIR), 19(6): e233. doi: 10.2196/jmir.7347

Bero, L. A. & Grundy, Q. (2016). Why having a (non-financial) interest is not a conflict of interest. PLoS Biology, 14(12): e2001221. doi: 10.1371/journal.pbio.2001221

Grundy, Q. (2016). Why marketing to nurses matters. American Nurse Today, 11(11), 28-29, 31

Grundy, Q., Wang, Z. & Bero, L. A. (2016). Challenges in assessing mobile health app quality: A systematic review of prevalent and innovative methods. American Journal of Preventive Medicine. doi: 10.1016/j.amepre.2016.07.009

Grundy, Q., Fabbri, A., Swandari, S., Mintzes, B. & Bero, L. (2016). The inclusion of nurses in pharmaceutical industry-sponsored events: Guess who is also coming to dinner? JAMA Internal Medicine. doi: 10.1001/jamainternmed.2016.5276

Grundy, Q. & Malone, R. E. (2016). The 'as-if' world of nursing practice: Nurses, marketing and decision making. Advances in Nursing Science. 10.1097/ANS.0000000000000143 (full text here)

Grundy, Q. (2016). "Whether something cool is good enough": The role of evidence, sales representatives and nurses' expertise in hospital purchasing decisions. Social Science and Medicine, 165, 82-91. doi: 10.1016/j.socscimed.2016.07.042

Grundy, Q., Bero, L., & Malone, R. E. (2016). Marketing and the most trusted profession: The invisible interactions between registered nurses and industry. Annals of Internal Medicine, 164(11), 733-739. doi:10.7326/M15-2522

Smith, E. A., Grundy, Q., & Malone, R. E. (2015). “It’s not a priority when we're in combat”: Public health professionals and military tobacco control policy. American Journal of Public Health, 105(4), 660-664.

Yonge, O., Myrick, F. & Ferguson, L. & Grundy, Q. (2015). Lessons about boundaries and reciprocity in rural-based preceptorships. Quality Advancement in Nursing Education, 1(2), Article 4. doi: 10.17483/2368-6669.1002

Grundy. Q., Smith, E. A., & Malone, R. E. (2014). “Throwing a rock at their armored tank”: Civilian authority and military tobacco control. BMC Public Health, 14(1292). doi:10.1186/1471-2458-14-1292

Grundy, Q. (2014). “My love-hate relationship”: Ethical issues associated with nurses’ interactions with industry in clinical practice. Nursing Ethics, 21(5), 554-564. doi: 10.1177/0969733013511360

Grundy, Q., Bero, L., & Malone, R. (2013) Interactions between non-physician clinicians and industry: A systematic review. PLoS Medicine, 10(11): e1001561. doi: 10.1371/journal.pmed.1001561

Yonge, O., Myrick F., Ferguson, L., & Grundy, Q. (2013). Multiple lenses: Rural landscape through the eyes of nurse preceptors and students. Journal of Rural and Community Development, 8(1), http://www.jrcd.ca/.

Yonge, O., Myrick, F., Ferguson, L. & Grundy, Q. (2013). “You have to rely on everyone and they on you”: Interdependence and the team-based rural nursing preceptorship. Online Journal of Rural Nursing and Health Care, 13(1).

Yonge, O., Myrick, F., Ferguson, L. & Grundy, Q. (2013). Nursing preceptorship experiences in rural settings: “I would work here for free.” Nurse Education in Practice, 13(2), 125-31. doi: 10.1016/j.nepr.2012.08.001

Grundy, Q. (2012). The Physicians Payments Sunshine Act and the unaddressed role of nurses: An interest group analysis. Policy, Politics & Nursing Practice, 13(3), 154-161. doi: 10.1177/1527154412465196

Malone, R., Grundy, Q., & Bero, L. (2012). Tobacco industry denormalisation as a tobacco control intervention: A review. Tobacco Control, 21(2), 162-170. doi:10.1136/tobaccocontrol-2011-050200

Yonge, O., Myrick, F., Ferguson, L. & Grundy, Q. (2011). Rural Preceptors’ Concerns with Nursing Student Evaluation (Chapter 18). In A. Bushy & D. Molinari (Eds.) Rural Nurse: Transition to Practice. New York, NY: Springer, pp. 207-226.

Luhanga, F., Billay, D., Grundy, Q., Myrick, F., & Yonge, O. (2010).  The one-to-one relationship: Is it really key to an effective preceptorship experience? International Journal of Nursing Education Scholarship, 7(1), Article 21.